Home Health Care Regeneron, Sanofi will invest $2B for new cancer drugs

Regeneron, Sanofi will invest $2B for new cancer drugs

SHARE

The global collaboration partners aim to discover, develop and market new drug treatments in the emerging field of immuno-oncology.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email